Print

Progenics Pharmaceuticals, Inc. (PGNX) Announces Key Strategic Hire  
7/1/2013 1:14:39 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., July 1, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced the appointment of Hagop Youssoufian, MD, as Executive Vice President, Research & Development. Dr. Youssoufian will oversee the Company's global research and development efforts and will be instrumental in driving the strategic trajectory of the Company's developmental stage oncology assets.

Help employers find you! Check out all the jobs and post your resume.

//-->